Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ASACOL
- The Efficacy of Asacol (Mesalazine) Suppository on the Treatment of Diarrhea-Induced Acute Fissure
- Use of Rectal Dialysis Technique to Measure Rectal 5-ASA Levels in Healthy Volunteers Receiving Asacol
- Mercaptopurine Therapy in Ulcerative Colitis
- Aminosalicylic Acid Withdrawal Study in Long Standing Inactive Ulcerative Colitis
- Effects of Mesalamine and Amitriptyline on Irritable Bowel Syndrome
- Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis
- TP05 for the Treatment of Mild to Moderate Active Ulcerative Colitis (UC)
- Mesalazine Treatment in IBS (The MIBS Study)
- Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study)
- Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase
- Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis
- Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis
- A BE Study Comparing Mesalamine 400 mg to ASACOL® 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis
- Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis
- Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis
- Pharmacokinetics of Asacol 2.4 g/Day and Lialda 2.4 g/Day in Healthy Volunteers
- Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis
- The Colitis Once Daily Asacol Study
- (CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis
- Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)
- Asacol Acute Diverticulitis(DIVA)Study
- Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative Colitis
- A Comparison of Once a Day Dose Compared to 2 Doses/Day
- Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis
- A Double Blind Study for the Treatment of Acute Ulcerative Colitis
- Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients
- Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis
- A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease
- A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis.
- Asacol Dosing Study for Active Ulcerative Colitis
- Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis
- Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONIC
- CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission
- Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis
- Monoclonal Antibody Treatment of Crohn's Disease
Clinical trials list
click for details